Hawaii Pacific Neuroscience Clinical Research Center (CRC) proven model, and combined years of experience affords us the ability to provide Hawaii patients with groundbreaking new neuroscience treatment options.
The CRC is fully staffed with full time investigators and credentialed, experienced and qualified research raters and staff. The CRC is a highly sought after site and have a national reputation for successful completion and recruitment including rapid site start up.
The CRC has successfully completed over 100 phase 0, I, II, III and IV clinical trials and actively involved in investigations of:
Few examples of successfully investigated, FDA approved and launched products include Cenobamate for Epilepsy, Inbrija for Parkinson’s, Kesimpta for MS, Daridorexant for Insomnia in recent years.
The Neuroscience Center with its Centers of Excellence for disease specific disorders are fully integrated so that patients seen at centers of excellence can have easy access to the benefits of world class groundbreaking clinical research at the Clinical Research Center specially equipped with: